Gain, loss and agreement between respiratory specialists and generalists in the diagnosis of asthma;Ganancia, pérdida y concordancia en el diagnóstico de asma entre neumólogos y no neumólogos

Archivos de Bronconeumologia

Volumn 37, Issue 4, 2001, Pages 171-176

  Pellicer, C ^a   Ramirez R ^a   Perpina M ^b   Cremades, M J ^a   Fullana, J ^a   Garcia I ^a   Gilabert, M J ^a  

^a HOSPITAL FRANCESC DE BORJA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Asthma in primary care and specialized care; Bronchial asthma: Diagnostic agreement; Under diagnosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ASTHMA; FEMALE; GENERAL PRACTICE; HUMAN; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT REFERRAL; PULMONOLOGY; REGRESSION ANALYSIS; RISK;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ASTHMA; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; ODDS RATIO; PULMONARY DISEASE (SPECIALTY); REFERRAL AND CONSULTATION; REGRESSION ANALYSIS;

EID: 0035316416     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(01)75046-6     Document Type: Article

References (37)

1. Woolcock AJ. Worldwide differences in asthma prevalence and mortality. Why is asthma mortality so low in the U.S.A.? Chest 1986; 90: 40S-45S.
2. Asher MI, Pattemore PK, Harrison AC, Mitchell EA, Rea HH, Stewart W et al. International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis 1988; 136: 524-529.
3. Grupo Español del Estudio Europeo del Asma. Estudio Europeo del Asma: prevalencia de síntomas relacionados con el asma en cinco áreas españolas. Med Clin (Barc) 1995; 104: 487-492.
4. Grupo Español del Estudio Europeo del Asma. Estudio Europeo del Asma. Prevalencia de hiperreactividad bronquial y asma en adultos jóvenes de cinco áreas españolas. Med Clin (Barc) 1996; 106: 761-767.
5. De Marco R, Cerveri I, Bugiani M, Verlato G. An undetected burden of asthma in Italy: the relationship between clinical and eidemiological diagnosis of asthma. Eur Respir J 1988; 11: 599-605.
6. Martínez-Moratalla J, Almar E, Sunyer J, Ramos J, Pereira A, Payo F et al, y el Grupo Europeo del Asma. Identificación y tratamiento de individuos con criterios epidemiológicos de asma en adultos jóvenes de cinco áreas españolas. Arch Bronconeumol 1999; 35: 223-228.
7. Enright PL, MacClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD, for the Cardiovascular Health Study Research Group. Underdiagnosis and undertreatment of asthma in he elderly. Chest 1999; 116: 603-613.
8. Espinosa de los Monteras MJ, González A, Rodríguez F, Gabriel R, Ancoechea J. Análisis descriptivo (características clínicas y funcionales) de la población asmática de un área sanitaria. Arch Bronconeumol 1999; 35: 518-524.
9. Pellicer C, Lorente P, Valero P, Cremades MJ, Fullana J, Perpiñà M et al. Estudio descriptivo de los pacientes diangosticados de asma en una consulta neumológica comarcal. Arch Bronconeumol 1999; 35: 167-172.
10. Abdulwadud QA, Abramson MJ, Light L, Thien FC, Walters EH. Comparison of patients with asthma managed in general practice and in a hospital clinic. Med J Aust 1999; 171: 72-75.
11. Li JT, Sheeler RD, Offord KP, Patel AM, Dupras DM. Consultation for asthma: results of a generalist survey. Ann Allergy Immunol 1999; 83: 203-206.
12. Johnson PH, Wilkinson I, Stuherland AM, Johnston ID, Hall IP. Improving communication between hospital and primary care increases follow-up rates for asthmatic patients following casualty attendance. Respir Med 1998; 92: 289-291.
13. National Asthma Education and Prevention Program. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. Bethseda: National Institutes of Health, 1997. Publicación n.o 97:4051
14. Sociedad Española de Neumología y Cirugía Torácica y Sociedad Española de Medicina de Familia y Comunitaria. Recomendaciones para la atención del paciente con asma. Arch Bronconeumol 1998; 34: 394-399.
15. Pellicer C, Fullana J, Cremades MJ, Rivera ML, Perpiñá M. Perfil de una consulta neumológica de ámbito comarcal. Arch Bronconeumol 1996; 32: 447-452.
16. Quanjer Ph H, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernaul JC. Lung volumen and forced ventilatory flows. Eur Respir J 1993; 6 (Supl 6): 5-40.
17. Dekker FW, Schrier AC, Sterk PJ, Dijkman JM. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992; 47: 162-166.
18. Quackenboss J, Lebowitz MD, Krzyzanowski M. Normal range of diurnal changes in expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991; 143: 323-330.
19. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBIAVHO Workshop Report. National Institutes of Health, 1995. Publication n.o 95-3659.
20. Chathman M, Bleecker ER, Norman PhL, Mason P. A screening test for airway reactivity. An abreviated methacholine inhalation challenge. Chest 1982; 82: 15-18.
21. Pellicer Císcar C, Sanchis Aldás J. Prueba de provocación farmacológica bronquial. En: Perpiñá Tordera M, editor. Hiperreactividad bronquial inespecífica. Barcelona: Doyma, 1993; 99-116.
22. Dreborg S. Skin tests used in type I allergy testing. Allergy 1989; 44 (Supl 10): 22-31.
23. Kramer MS, Feinstein AR. The biostatistic of concordance. Clin Pharmacol Ther 1981; 29: 111-123.
24. Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. Br Med J 1992; 304: 1491-1494.
25. Kleinbaum DJ. Una introducción al análisis de regresión logística. En: Porta, Álvarez-Dardet, editores. Revisiones en salud pública, 3. Barcelona: Masson, 1993.
26. Roca J, Sanchis J, Agustí-Vidal A, Segarra F, Navajas D, Rodríguez-Roisín R et al. Spirometric reference values from a mediterranean population. Bull Eur Physiopathol Respir 1986; 22: 217-224.
27. Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J 1999; 14: 951-957.
28. Enarson DA, Vedal S, Schulzer M, Dybuncio A, Chan-Yeung M, Asthma, asthma like symptoms, chronic bronchitis and the degree of bronchial hyperresponsiveness in epidemiology surveys. Am Rev Respir Dis 1987; 136: 613-617.
29. Nish WA, Shcwietz LA. Underdiagnosis of asthma in young adults presenting for USAF basic training. Ann Allergy 1992; 69: 239-242.
30. Hahn DL, Beasley JW, and the Wisconsin Research Network (WReN). Asthma Prevalence Study Group. Diagnosed and possible undiagnosed asthma: a Wisconsin Research Network (WReN) Study. J Fam Pract 1994; 38: 373-379.
31. Pedersen S, Warener JO, Price JF. Early use of inhaled steroids in children with asthma. Clin Exp Allergy 1997; 27: 995-1006.
32. Perpiñá Tordera M. Remodelado de las vías aéreas en el asma. Arch Bronconeumol 1999; 35: 199-201.
33. Elias JA. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 2000; 161: 168S-171S.
34. Jansen DF, Rijcken B, Schouten JP, Kraan J, Weiss ST, Timens W et al. The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to hyperresponsiveness. Am J Respir Crit Care Med 1999; 159: 924-931.
35. European Community Respiratory Health Survey (ECRHS)-Italy. Determinats of bronchial responsiveness in the European Community Respiratory Health Survey in Italy: evidence of an indepenent role of atopy, total serum IgE levels, and asthma symptons. Allergy 1998; 53: 673-681.
36. Sunyer J, Antó JM, Castellsagué J, Soriano JB, Roca J, and the Spanish Group of the European Study of Asthma. Eur Respir J 1996; 9: 1880-1884.
37. Neville RG, Higgins BC. Providing better asthma care: what is there left to do? Thorax 1999; 54: 813-817.